Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04554394 · ClinicalTrials.gov registry record · NA
CellFX System for the Treatment of Cutaneous Non-Genital Warts
A NA study, sponsored by Pulse Biosciences.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT04554394 is a NA study that has completed, run by Pulse Biosciences. The registered enrollment target is 62 participants.
The verdict
NCT04554394, a NA study, has completed, sponsored by Pulse Biosciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
This prospective, non-randomized, multicenter pivotal study is designed to evaluate the safety and effectiveness of the CellFX System in patients with cutaneous non-genital warts on all areas of the body, excluding the face.
Interventions
- DEVICE CellFX Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2019-07-17 |
| Est. Completion | 2020-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04554394
The ClinicalTrials.gov registry entry for NCT04554394 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pulse Biosciences, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CellFX Device is the first listed.
NCT04554394 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04554394 about?
NCT04554394 is a clinical study titled "CellFX System for the Treatment of Cutaneous Non-Genital Warts". This prospective, non-randomized, multicenter pivotal study is designed to evaluate the safety and effectiveness of the CellFX System in patients with cutaneous non-genital warts on all areas of the body, excluding the face.
What is the current status of trial NCT04554394?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2019-07-17. Estimated completion is 2020-12-01.
What interventions are being tested in trial NCT04554394?
The interventions under investigation include: CellFX Device (DEVICE).
Who is sponsoring clinical trial NCT04554394?
This trial is sponsored by Pulse Biosciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.